These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 17665321

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. American Society of Clinical Oncology--43rd annual meeting. Research into therapeutics: Part 4.
    Walker K, Kibble A, Shumoogam J.
    IDrugs; 2007 Aug; 10(8):523-6. PubMed ID: 17665323
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Summary of presentations from the 46th annual meeting of the American Society Of Clinical Oncology (2010): focus on developmental therapeutics related to lung cancer.
    Morgensztern D, Pennell NA, Subramanian J, Govindan R.
    Clin Lung Cancer; 2011 Mar; 12(2):94-9. PubMed ID: 21550555
    [Abstract] [Full Text] [Related]

  • 5. [New antitumor derivatives of vinblastine].
    Bölcskei H, Szántay C, Mák M, Balázs M, Szántay C.
    Acta Pharm Hung; 1998 Mar; 68(2):87-93. PubMed ID: 9592933
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. American society of clinical oncology - 45th annual meeting. Part 2.
    Lakeram M, Kibble A.
    IDrugs; 2009 Jul; 12(7):404-8. PubMed ID: 19579155
    [No Abstract] [Full Text] [Related]

  • 9. American Society of Clinical Oncology-39th Annual Meeting. Investigational Drugs. 31 May-3 June 2003, Chicago, IL, USA.
    Erlich R, Durrance A.
    IDrugs; 2003 Jul; 6(7):628-30. PubMed ID: 12906005
    [No Abstract] [Full Text] [Related]

  • 10. Glyn Edwards talks about cancer drug development at Antisoma. Interview by Ulrike Knies-Bamforth and Dan Huke.
    Edwards G.
    Drug Discov Today; 2005 Nov 15; 10(22):1491-4. PubMed ID: 16257369
    [Abstract] [Full Text] [Related]

  • 11. [Coronary disease and vinorelbine].
    Ruffenach M, Missler J, Meier M, Salen JM.
    Rev Pneumol Clin; 1994 Nov 15; 50(2):94. PubMed ID: 7839061
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. American Chemical Society--229th National Meeting. Oncology.
    Chan D, Mackonochie M.
    IDrugs; 2005 Apr 15; 8(4):280-2. PubMed ID: 15800795
    [No Abstract] [Full Text] [Related]

  • 14. From silos to a critical path of new agent development: a paradigm to revolutionize clinical research.
    Benson AB.
    J Clin Oncol; 2008 Apr 20; 26(12):1924-5. PubMed ID: 18421045
    [No Abstract] [Full Text] [Related]

  • 15. The epothilones: how pharmacology relates to clinical utility.
    Michaud LB.
    Ann Pharmacother; 2009 Jul 20; 43(7):1294-309. PubMed ID: 19584389
    [Abstract] [Full Text] [Related]

  • 16. American Society of Clinical Oncology-39th Annual Meeting. Taxanes. 31 May-3 June 2003, Chicago, IL, USA.
    Erlich R, Durrance A.
    IDrugs; 2003 Jul 20; 6(7):621-2. PubMed ID: 12906002
    [No Abstract] [Full Text] [Related]

  • 17. American Association for Cancer Research 98th Annual Meeting. Anticancer agents - Part II.
    Filson S.
    IDrugs; 2007 Jun 20; 10(6):359-61. PubMed ID: 17641994
    [No Abstract] [Full Text] [Related]

  • 18. Cancer research. Can fasting blunt chemotherapy's debilitating side effects?
    Couzin J.
    Science; 2008 Aug 29; 321(5893):1146-7. PubMed ID: 18755948
    [No Abstract] [Full Text] [Related]

  • 19. American Association for Cancer Research 98th Annual Meeting. Anticancer agents - Part I.
    Kneller S.
    IDrugs; 2007 Jun 29; 10(6):356-8. PubMed ID: 17641993
    [No Abstract] [Full Text] [Related]

  • 20. Reflections on medical oncology: 25 years of clinical trials--where have we come and where are we going?
    Booth CM, Tannock I.
    J Clin Oncol; 2008 Jan 01; 26(1):6-8. PubMed ID: 18165630
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.